CIK 0001488039
- Non-accelerated filer
- Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264753208
- Phone
- +1 206-588-0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-27 | QUAY STEVEN C President & CEO | Grant or award | +65,000 | 88,038 | ||
| 2026-01-20 | QUAY STEVEN C President & CEO | Grant or award | +331,674 | 345,572 | ||
| 2026-01-20 | QUAY STEVEN C President & CEO | Grant or award · Stock Options (right to buy) | +950,000 | $0.60 | $573K | 950,000 |
| 2026-01-20 | QUAY STEVEN C President & CEO | Grant or award | +325,203 | 339,101 | ||
| 2026-01-20 | QUAY STEVEN C President & CEO | Grant or award · Stock Options (right to buy) | +950,000 | $0.60 | $573K | 950,000 |
| 2025-05-21 | QUAY STEVEN C President & CEO | Purchase | +11,239 | $0.88 | $10K | 13,898 |
| 2025-05-15 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,366,062 | 1,366,062 | ||
| 2024-06-27 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,795,100 | 1,795,100 | ||
| 2023-03-02 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,873,100 | 1,873,100 | ||
| 2022-02-24 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,900,000 | 1,900,000 | ||
| 2021-05-14 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,900,000 | 1,900,000 | ||
| 2021-05-14 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,900,000 | 1,900,000 | ||
| 2020-04-09 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2020-04-09 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (Right to Buy) | +1,305,000 | 1,305,000 | ||
| 2019-01-13 | QUAY STEVEN C President & CEO | Returned to the company · Stock Option (Right to Buy) | −2,300,000 | 0 | ||
| 2019-01-13 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (Right to Buy) | +2,300,000 | 2,300,000 | ||
| 2018-06-27 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +2,300,000 | 2,300,000 | ||
| 2018-05-30 | QUAY STEVEN C President & CEO | Purchase · Series B Convertible Preferred Stock | +8 | $1,000.00 | $8K | 8 |
| 2018-05-30 | QUAY STEVEN C President & CEO | Purchase · Warrants | +2,272 | $1,000.00 | $2.3M | 2,272 |
| 2017-05-24 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +575,893 | 651,785 |
Page 1 of 2 · 28 trades